Trials Open to Enrollment
AIDS Clinical Trials: New Trials Open to Enrollment http://www.actis.org/actinewl.htmi The purpose of this Glaxo Wellcome sponsored study is to obtain preliminary evidence of antiretroviral activity of 1592U89 when administered in combination with other specific NRTI agents in NRTI experienced patients and to assess the safety and tolerance of multiple oral doses of 1592U89 when administered in combination with specific marketed NRTIs. For more information, view the Protocol Database record. D A Phase III, Randomized, Double Blind, Multicenter Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex. FDA 238B. Drug: 1592U89. The purpose of this Glaxo Wellcome sponsored study is to evaluate the benefit of adding 1592U89 to current antiretroviral therapies for AIDS dementia complex and to assess the safety and tolerance of the treatment regimens. For more information, view the Protocol Database record. l Apheresis Procedures to Obtain Plasma or Lymphocytes for In Vitro Studies. NIAID 81 I-164. The purpose of this National Institute of Allergy & Infectious Diseases study is to improve the understanding of the role of cellular factors in determining the levels of HIV produced from infected cells. For more information, view the Protocol Database record. Q The Use of Bacteriophage phi x174 to Assess the Immune Competence of HIV-Infected Patients in Vivo. NIAID 96 1-58. Drug: Bacteriophage phi X 174. The purpose of this National Institute of Allergy & Infectious Diseases study is to assess the safety of bacteriophage phi X174 immunization in HIV-infected patients at different stages of disease. To evaluate the ultility of bacteriophage phi X174 as a tool to qualitatively and quantitatively assess the immune competence of HIV-infected patients at different stages of disease. For more information, view the Protocol Database record. D A Phase III Dosing Study of the Safety and Antiretroviral Activity of Hydroxyurea Alone and in Combination With ddl Compared With ddl Alone in Subjects With HIV Infection. NIAID ACTG 307. Drugs: Didanosine, Hydroxyurea. The purpose of this AIDS Clinical Trials Group study is to determine the safety and tolerability of hydroxyurea at two doses alone and in combination with didanosine (ddl). To compare the short term antiviral effect of ddl monotherapy versus hydroxyurea plus ddl, as measured by plasma RNA levels at 8 weeks of therapy. For more information, view the Protocol Database record. L An Open-Label, Randomized, Three-Arm, Comparative Trial of a Caloric Supplement With Peptides and Medium-Chain Triglycerides Versus a Caloric Supplement With Whole Protein and Long-Chain Triglycerides Versus No Caloric Supplement for the Prevention of Weight Loss in Individuals With AIDS Who Take a Daily Multivitamin and Mineral Supplement. NIAID CPCRA 038. The purpose of this Community Programs for Clinical Research on AIDS study is to compare a caloric supplement containing peptides and medium-chain triglycerides, a caloric supplement containing whole protein and long-chain triglycerides, and no caloric supplement for the prevention of weight loss in individuals with AIDS who take a daily multivitamin and mineral supplement. For more information, view the Protocol Database record.
About this Item
- Title
- Trials Open to Enrollment
- Author
- AIDS Clinical Trials Information Service
- Canvas
- Page 6
- Publication
- AIDS Clinical Trials Information Service
- 1997-03-17
- Subject terms
- announcements
- Series/Folder Title
- Disease Management > AIDS Vaccines > Clinical Trials > Protocol listings
- Item type:
- announcements
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0342.002
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0342.002/6
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0342.002
Cite this Item
- Full citation
-
"Trials Open to Enrollment." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0342.002. University of Michigan Library Digital Collections. Accessed June 10, 2025.